The Changes in Medication Prescribing Among the Older People with Cognitive Impairment in the Acute Care Setting

References

• World Health Organization. World Report on Ageing and Health. Geneva: World Health Organization; 2015 Available from http://www.who.int/ageing/events/world-report-2015-launch. Accessed 912, 2019.
   Google Scholar
• Population projections australia, 2017 to 2066, catalogue no. 3222.0, ABS. Canberra: australian bureau of statistics (ABS); 2018 Available from: https://www.abs.gov.au/3222.0MediaRelease 12017 (base)-2066. Accessed 912, 2019..
   Google Scholar
• Andrew MK, Rockwood K. Making our health and care systems fit for an ageing population: considerations for Canada. Can Geriatr J. 2014;17(4):133–135. doi:10.5770/cgj.17.16325452826
   PubMedGoogle Scholar
• Cornwell J, Levenson R, Sonola L, Poteliakhoff E. Continuity of care for older hospital patients: a call for action; 2012 Available from: http://www.kingsfund.org.uk/publications/continuity-care-older-hospitalpatients. Accessed 912, 2019..
   Google Scholar
• Pedersen MK, Meyer G, Uhrenfeldt L. Risk factors for acute care hospital readmission in older persons in western countries: a systematic review. JBI Database System Rev Implement Rep. 2017;15(2):454–485. doi:10.11124/JBISRIR-2016-003267
   PubMedGoogle Scholar
• Li CL, Chu SJ, Sheu JT, Huang LY. Impact of physical activity on hospitalization in older adults: a nationwide cohort from Taiwan. Arch Gerontol Geriatr. 2011;53(2):141–145. doi:10.1016/j.archger.2010.09.01421067830
   PubMed Web of Science ®Google Scholar
• Albert SM, Colombi A, Hanlon J. Potentially inappropriate medications and risk of hospitalization in retirees: analysis of a US retiree health claims database. Drugs Aging. 2010;27(5):407–415. doi:10.2165/11315990-000000000-0000020450238
   PubMed Web of Science ®Google Scholar
• Reynish EL, Hapca SM, De Souza N, Cvoro V, Donnan PT, Guthrie B. Epidemiology and outcomes of people with dementia, delirium, and unspecified cognitive impairment in the general hospital: prospective cohort study of 10,014 admissions. BMC Med. 2017;15(1):140. doi:10.1186/s12916-017-0899-028747225
   PubMed Web of Science ®Google Scholar
• Wilson RS, Hebert LE, Scherr PA, Dong X, Leurgens SE, Evans DA. Cognitive decline after hospitalization in a community population of older persons. Neurology. 2012;78(13):950–956. doi:10.1212/WNL.0b013e31824d589422442434
   PubMed Web of Science ®Google Scholar
• Marcantonio ER. Delirium in hospitalized older adults. N Eng J Med. 2017;377(15):1456–1466. doi:10.1056/NEJMcp1605501
   PubMed Web of Science ®Google Scholar
• Leto L, Feola M. Cognitive impairment in heart failure patients. J Geriatr Cardiol. 2014;11(4):316–328. doi:10.11909/j.issn.1671-5411.2014.04.00725593581
   PubMedGoogle Scholar
• Morris C, Mitchell JW, Moorey H, Younan HC, Tadros G, Turner AM. Memory, attention, and fluency deficits in COPD may be a specific form of cognitive impairment. ERJ Open Res. 2019;5(2):00229–2018. doi:10.1183/23120541.00229-201831149625
   PubMedGoogle Scholar
• Fogg C, Griffiths P, Meredith P, Bridges J. Hospital outcomes of older people with cognitive impairment: an integrative review. Int J Geriatr Psychiatry. 2018;33(9):1177–1197. doi:10.1002/gps.4919
   PubMed Web of Science ®Google Scholar
• Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2012;5:CD008165.
   PubMed Web of Science ®Google Scholar
• Clague F, Mercer SW, McLean G, Reynish E, Guthrie B. Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data. Age Ageing. 2017;46(1):33–39. doi:10.1093/ageing/afw17628181629
   PubMed Web of Science ®Google Scholar
• Hubbard RE, Peel NM, Scott IA, et al. Polypharmacy among inpatients aged 70 years or older in Australia. Med J Aust. 2015;202(7):373–377. doi:10.5694/mja13.0017225877120
   PubMed Web of Science ®Google Scholar
• Campanelli CM. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–631. doi:10.1111/j.1532-5415.2012.03923.x22376048
   PubMed Web of Science ®Google Scholar
• Fick DM Semla TP Beizer J, et alBy the 2019 American geriatrics society beers criteria update expert panel. American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–2246. doi:10.1111/jgs.1370226446832
   PubMed Web of Science ®Google Scholar
• Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (screening tool of older person’s prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83. doi:10.5414/CPP4607218218287
   PubMed Web of Science ®Google Scholar
• Sönnerstam E, Sjölander M, Gustafsson M. An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list. Eur J Clin Pharmacol. 2017;73(6):735–742. doi:10.1007/s00228-017-2218-228246889
   PubMed Web of Science ®Google Scholar
• Bajcar JM, Wang L, Moineddin R, Nie JX, Tracy CS, Upshur REG. From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997–2006. BMC Fam Pract. 2010;11(1):75. doi:10.1186/1471-2296-11-7520929561
   PubMed Web of Science ®Google Scholar
• Jay S, Babak BB, Sarah A. Empagliflozin in the treatment of type 2 diabetes: evidence to date. Drug Des Devel Ther. 2015;9:5793–5803. doi:10.2147/DDDT.S69926
   Web of Science ®Google Scholar
• Gao L, Maidment I, Matthews FE, Robinson L, Brayne C. Medication usage change in older people (65+) in England over 20 years: findings from CFAS I and CFAS II. Age Ageing. 2018;47(2):220–225. doi:10.1093/ageing/afx15829036509
   PubMed Web of Science ®Google Scholar
• Fried TR, Tinetti ME, Iannone L. Primary care clinicians’ experiences with treatment decision making for older persons with multiple conditions. Arch Intern Med. 2011;171(1):75–80. doi:10.1001/archinternmed.2011.42420837819
   PubMedGoogle Scholar
• Oktora MP, Denig P, Bos JHJ, Schuiling-Veninga CCM, Hak E. Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States. PLoS One. 2019;14(3):e0214240. doi:10.1371/journal.pone.021424030901377
   PubMed Web of Science ®Google Scholar
• Charlesworth CJ, Smit E, Lee DS, Alramadhan F, Odden MC. Polypharmacy among adults aged 65 years and older in the United States: 1988–2010. J Gerontol a Biol Sci Med Sci. 2015;70(8):989–995. doi:10.1093/gerona/glv01325733718
   PubMed Web of Science ®Google Scholar
• Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Physician. 2017;63(5):354–364.28500192
   PubMed Web of Science ®Google Scholar
• Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989–995. doi:10.1016/j.jclinepi.2012.02.01822742913
   PubMed Web of Science ®Google Scholar
• Maher RL Jr, Hanlon JT, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65. doi:10.1517/14740338.2013.82766024073682
   PubMed Web of Science ®Google Scholar
• Rodrigues MC, Oliveira C. Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review. Rev Lat Am Enfermagem. 2016;24:e2800. doi:10.1590/1518-8345.1316.280027598380
   PubMed Web of Science ®Google Scholar
• Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–1196. doi:10.1080/14740338.2018.154684130540223
   PubMed Web of Science ®Google Scholar
• Moore AR, O’Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging. 1999;15(1):15–28. doi:10.2165/00002512-199915010-0000210459729
   PubMed Web of Science ®Google Scholar
• Reeve E, Trenaman SC, Rockwood K, Hilmer SN. Pharmacokinetic and pharmacodynamic alterations in older people with dementia. Expert Opin Drug Metab Toxicol. 2017;13(6):651–668. doi:10.1080/17425255.2017.132587328460576
   PubMed Web of Science ®Google Scholar
• Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J of Clin Pharmacol. 2004;57(1):6–14. doi:10.1046/j.1365-2125.2003.02007.x14678335
   PubMed Web of Science ®Google Scholar
• Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med. 2005;165(1):68–74. doi:10.1001/archinte.165.1.6815642877
   PubMedGoogle Scholar
• Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol. 2010;69(5):543–552. doi:10.1111/j.1365-2125.2010.03628.x20573091
   PubMed Web of Science ®Google Scholar
• Chen CC, Cheng SH. Potentially inappropriate medication and health care outcomes: an instrumental variable approach. Health Serv Res. 2016;51(4):1670–1691. doi:10.1111/1475-6773.1241726601656
   PubMed Web of Science ®Google Scholar
• Poudel A, Peel NM, Nissen L, Mitchell C, Gray LC, Hubbard RE. Potentially inappropriate prescribing in older patients discharged from acute care hospitals to residential aged care facilities. Ann Pharmacother. 2014;48(11):1425–1433. doi:10.1177/106002801454856825159001
   PubMed Web of Science ®Google Scholar
• Widagdo IS, Nyfort-Hansen K, Kowalski SR. Prevalence of potentially inappropriate medication use in elderly hospitalized patients. J Pharm Pract Res. 2011;41(2):122–125. doi:10.1002/j.2055-2335.2011.tb00678.x
   Google Scholar
• Wahab MS, Nyfort-Hansen K, Kowalski SR. Inappropriate prescribing in hospitalised Australian elderly as determined by the STOPP criteria. Int J Clin Pharm. 2012;34(6):855–862. doi:10.1007/s11096-012-9681-822864867
   PubMed Web of Science ®Google Scholar
• Basger BJ, Chen TF, Moles RJ. Application of a prescribing indicators tool to assist in identifying drug-related problems in a cohort of older Australians. Int J Pharm Pract. 2012;20(3):172–182. doi:10.1111/j.2042-7174.2011.00177.x22554160
   PubMedGoogle Scholar
• Redston MR, Hilmer SN, McLachlan AJ, Clough AJ, Gnjidic D. Prevalence of potentially inappropriate medication use in older inpatients with and without cognitive impairment: a systematic review. J Alzheimers Dis. 2018;61(4):1639–1652. doi:10.3233/JAD-17084229278890
   PubMed Web of Science ®Google Scholar
• von Renteln-kruse W, Neumann L, Klugmann B, et al. Geriatric patients with cognitive impairment: patient characteristics and treatment results on a specialized ward. Dtsch Arztebl Int. 2015;11297:103–112.
   Google Scholar
• Gray LC, Bernabei R, Berg K, et al. Standardizing assessment of elderly people in acute care: the interRAI Acute Care instrument. J Am Geriatr Soc. 2008;56(3):536–541. doi:10.1111/j.1532-5415.2007.01590.x18179498
   PubMed Web of Science ®Google Scholar
• Lakhan P, Jones M, Wilson A, Courtney M, Hirdes J, Gray LC. A prospective cohort study of geriatric syndromes among older medical patients admitted to acute care hospitals. J Am Geriatr Soc. 2011;59(11):2001–2008. doi:10.1111/j.1532-5415.2011.03663.x22092231
   PubMed Web of Science ®Google Scholar
• Travers C, Byrne GJ, Pachana NA, Klein K, Gray L. Validation of the interRAI Cognitive Performance Scale against independent clinical diagnosis and the Mini-Mental State Examination in older hospitalized patients. J Nutr Health Aging. 2013;17(5):435–439. doi:10.1007/s12603-012-0439-823636544
   PubMed Web of Science ®Google Scholar
• Gray L, Ariño-Blasco S, Berg K, et al. interRAI Acute Care (AC) Assessment Form and User’s Manual. Washington, DC: interRAI; 2010.
   Google Scholar
• Gray LC, Berg K, Fries BE, et al. Sharing clinical information across care settings: the birth of an integrated assessment system. BMC Health Serv Res. 2009;9(1):71. doi:10.1186/1472-6963-9-7119402891
   PubMed Web of Science ®Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment; 2019 Oslo Available from: http://www.whocc.no/filearchive/publications/2019_guidelines_web.pdf. Accessed 95, 2019..
   Google Scholar
• Onder G, Liperoti R, Fialova D, et al. Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol a Biol Sci Med Sci. 2012;67(6):698–704. doi:10.1093/gerona/glr23322219520
   PubMed Web of Science ®Google Scholar
• Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997;157(14):1531–1536. doi:10.1001/archinte.1997.004403500310039236554
   PubMed Web of Science ®Google Scholar
• Fick DM Semla TP Steinman M, et al. By the 2019 American geriatrics society beers criteria update expert panel. American geriatrics society 2019 updated AGS beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694. doi:10.1111/jgs.1576730693946
   PubMed Web of Science ®Google Scholar
• Triplitt C. Drug interactions of medications commonly used in diabetes. Diabetes Spectrum. 2006;19(4):202–211. doi:10.2337/diaspect.19.4.202
   Google Scholar
• Reuters T. Micromedex^® HealthCare Series (Internet Database) Version 2.0. Greenwood Village, Colorado: Thomson Healthcare Inc; 2013 Available from http://www.micromedexsolutions.com. Accessed 95, 2019.
   Google Scholar
• Craftman AG, Johnell K, Fastbom J, Westerbotn M, von Strauss E. Time trends in 20 years of medication use in older adults: findings from three elderly cohorts in Stockholm, Sweden. Arch Gerontol Geriatr. 2016;63:28–35. doi:10.1016/j.archger.2015.11.01026791168
   PubMed Web of Science ®Google Scholar
• How CH. Novel oral anticoagulants for atrial fibrillation. Singapore Med J. 2015;56(12):657–658. doi:10.11622/smedj.201518426702159
   PubMed Web of Science ®Google Scholar
• Haasum Y, Fastbom J, Fratiglioni L, Kareholt I, Johnell K. Pain treatment in elderly persons with and without dementia: a population-based study of institutionalized and home-dwelling elderly. Drugs Aging. 2011;28(4):283–293. doi:10.2165/11587040-000000000-0000021428463
   PubMed Web of Science ®Google Scholar
• Franchi C, Tettamanti M, Pasina L, et al. Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM-Elderly Project 2000–2010. Eur J Clin Pharmacol. 2014;70(4):437–443. doi:10.1007/s00228-013-1621-624398968
   PubMed Web of Science ®Google Scholar
• Trifan A, Stanciu C, Girleanu I, et al. Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis. World J Gastroenterol. 2017;23(35):6500–6515. doi:10.3748/wjg.v23.i35.650029085200
   PubMed Web of Science ®Google Scholar
• Thong BKS, Ima-Nirwana S, Chin KY. Proton pump inhibitors and fracture risk: a review of current evidence and mechanisms involved. Int J Environ Res Public Health. 2019;16(9):pii:E1571. doi:10.3390/ijerph16091571
   Web of Science ®Google Scholar
• Othman F, Card TR, Crooks CJ. Proton pump inhibitor prescribing patterns in the UK: a primary care database study. Pharmacoepidemiol Drug Saf. 2016;25(9):1079–1087. doi:10.1002/pds.404327255671
   PubMed Web of Science ®Google Scholar
• Maes ML, Fixen DR, Linnebur SA. Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence. Ther Adv Drug Saf. 2017;8(9):273–297. doi:10.1177/204209861771538128861211
   PubMed Web of Science ®Google Scholar
• Nobili A, Marengoni A, Tettamanti M, et al. Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. Eur J Intern Med. 2011;22(6):597–602. doi:10.1016/j.ejim.2011.08.02922075287
   PubMed Web of Science ®Google Scholar
• Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107(31–32):543–551. doi:10.3238/arztebl.2010.054320827352
   PubMed Web of Science ®Google Scholar
• Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63(8):725–731. doi:10.1007/s00228-007-0324-217554532
   PubMed Web of Science ®Google Scholar
• Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol. 2012;3:73. doi:10.3389/fneur.2012.0007322586419
   PubMedGoogle Scholar
• Gustafsson M, Karlsson S, Lovheim H. Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units. BMC Pharmacol Toxicol. 2013;14(1):10. doi:10.1186/2050-6511-14-1023391323
   PubMed Web of Science ®Google Scholar
• Park H, Satoh H, Miki A, Urushihara H, Sawada Y. Medications associated with falls in older people: systematic review of publications from a recent 5-year period. Eur J Clin Pharmacol. 2015;71(12):1429–1440. doi:10.1007/s00228-015-1955-326407688
   PubMed Web of Science ®Google Scholar
• Raut A, Vohra F, Surve R, Pawar A. A study of prescribing pattern, comorbidities, and cost analysis in elderly hospitalized patients in Pune. Chrismed J Health Res. 2016;3(3):191–196. doi:10.4103/2348-3334.183739
   Google Scholar
• Wucherer D, Thyrian JR, Eichler T, et al. Drug-related problems in community-dwelling primary care patients screened positive for dementia. Int Psychogeriatr. 2017;29(11):1857–1868. doi:10.1017/S104161021700144228780910
   PubMed Web of Science ®Google Scholar
• Wucherer D, Eichler T, Hertel J, et al. Potentially inappropriate medication in community-dwelling primary care patients who were screened positive for dementia. J Alzheimers Dis. 2017;55(2):691–701. doi:10.3233/JAD-16058127716668
   PubMed Web of Science ®Google Scholar
• Kaufmann CP, Stampfli D, Hersberger KE, Lampert ML. Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ Open. 2015;5(3):e006376. doi:10.1136/bmjopen-2014-006376
   PubMed Web of Science ®Google Scholar
• Lau DT, Mercaldo ND, Harris AT, Trittschuh E, Shega J, Weintraub S. Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord. 2010;24(1):56–63. doi:10.1097/WAD.0b013e31819d6ec919561441
   PubMed Web of Science ®Google Scholar
• Shi BY. The importance and strategy of diabetes prevention. Chronic Dis Transl Med. 2016;2(4):204–207. doi:10.1016/j.cdtm.2016.11.01329063043
   PubMedGoogle Scholar
• Harrison SL, Kouladjian O’Donnell L, Bradley CE, et al. Associations between the drug burden index, potentially inappropriate medications and quality of life in residential aged care. Drugs Aging. 2018;35(1):83–91. doi:10.1007/s40266-017-0513-329322470
   PubMed Web of Science ®Google Scholar
• Kanagaratnam L, Dramé M, Trenque T, et al. Adverse drug reactions in elderly patients with cognitive disorders: a systematic review. Maturitas. 2016;85:56–63. doi:10.1016/j.maturitas.2015.12.01326857880
   PubMed Web of Science ®Google Scholar